UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000021398
Receipt No. R000024671
Scientific Title A Phase III, Open Label, Randomized, Controlled, Multicenter Study, comparing Eribulin with S1, to assess Health-related Quality of Life (HRQoL) in the Treatment of Her2 negative Metastatic Breast Cancer Patients
Date of disclosure of the study information 2016/03/16
Last modified on 2020/12/04 16:06:31

No. Disposal Last modified on Item of update
1 Insert 2016/03/08 19:38:10
2 Update 2016/03/29 18:35:16 Acronym
3 Update 2016/03/29 18:37:34 Primary outcomes
4 Update 2016/06/10 13:27:12 Last name of contact person
Last name of contact person
Email
Name of primary sponsor
Organization
5 Update 2016/06/10 13:30:13 Recruitment status
6 Update 2017/09/08 09:14:38 Last name of contact person
Last name of contact person
Institutions
7 Update 2018/11/01 15:59:15 Last name of contact person
Last name of contact person
Division name
8 Update 2020/05/11 12:23:22 Recruitment status
Date of IRB
Anticipated trial start date
9 Update 2020/12/04 16:06:31 UMIN ID2


Contact us.